Skip to main content

Table 1 Patients' molecular and clinical characteristics.

From: The frequency of NPM1 mutations in childhood acute myeloid leukemia

Patient No.

Nucleotide sequences

Sex

Age (years)

FAB Type

Karyotype

MLL rearrangement

FLT3 mutation

WBC

Blast Count in BM (%)

Survival

Wild type

gat ctc tgg cag tgg agg aag tct ctt taa gaa aat ag

1

gat ctc tgt ctg gca gtg gag gaa gtc tct tta aga aaa tag

M

8 years

M1

46, xy

N

None

23900

85%

Complete Remission

2

gat ctc tgg cag g gg agg aag c ct ctt taa gaa aat ag

F

13 years

M2

46, xx t(8;21) (q22;q22)

N

FLT3/ITD

7680

60%

Complete Remission